ClinicalTrials.Veeva

Menu

HIT in People With Type 1 Diabetes

L

Liverpool John Moores University

Status

Completed

Conditions

Type1diabetes

Treatments

Other: HIT
Other: MICT

Study type

Interventional

Funder types

Other

Identifiers

NCT03545841
T1D_PARTB

Details and patient eligibility

About

Few people with type 1 diabetes achieve exercise guidelines and many programmes designed to increase physical activity have failed. High-intensity interval training (HIT) has been shown to be a time-efficient alternative to traditional moderate-intensity continuous training (MICT) in various groups without type 1 diabetes. A single bout of HIT does not increase the risk of hypoglycaemia in people with type 1 diabetes. This study aimed to assess whether HIT a safe, effective and time-efficient training strategy to improve cardio-metabolic health and reduce the risk of hypoglycaemia in people with type 1 diabetes.

Full description

This study aimed to investigate whether 1) six weeks of high-intensity interval training (HIT) induces similar improvements in cardio-metabolic health markers as moderate-intensity continuous training (MICT) in people with type 1 diabetes, and 2) whether HIT abolishes acute reductions in plasma glucose observed following MICT sessions. Fourteen sedentary individuals with type 1 diabetes (n=7 per group) completed six weeks of HIT or MICT 3 times per week. Pre- and post-training measurements were made of 24h interstitial glucose profiles (using continuous glucose monitors (CGMS)) and cardio-metabolic health markers (V ̇O2peak, blood lipid profile and aortic pulse wave velocity; aPWV). Capillary blood glucose concentrations were assessed before and after exercise sessions throughout the training programme to investigate changes in blood glucose during exercise in the fed state.

Enrollment

14 patients

Sex

Volunteers

No Healthy Volunteers

Inclusion criteria

  • duration of type 1 diabetes >6 months
  • basal bolus regimen
  • no significant history of hyper- or hypoglycaemia (determined from medical history)

Exclusion criteria

duration of type 1 diabetes <6 months,

  • insulin pump therapy
  • significant history of hyper- or hypoglycaemia (determined from medical history)
  • obesity (BMI >30 kg∙m-2)
  • pregnancy or planning pregnancy
  • uncontrolled hypertension (>180/100 mmHg)
  • angina, autonomic neuropathy
  • taking any medication that affects heart rate
  • major surgery planned within 6 weeks of the study
  • severe nonproliferative
  • unstable proliferative retinopathy

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

14 participants in 2 patient groups

HIT training
Experimental group
Description:
6 weeks of high-intensity interval training (HIT)
Treatment:
Other: HIT
Moderate intensity training
Experimental group
Description:
6 weeks of moderate-intensity continuous training (MICT)
Treatment:
Other: MICT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems